330 likes | 586 Views
. . . . . . . . . . . . . . . . . . . . . . . . Hypertension Control in Europe andNorth America. 13.0%. 9.3%. 5.7%. 7.7%. 5.0%. 11.6%. 26.8%. 0%. 5%. 10%. 15%. 20%. 25%. 30%. USA. Canada. England . Finland. Germany . Spain . Italy. Control in %. Wolf-Maier K et al, Hypertension 2004;43:10-17. . Bri
E N D
1. HypertensionBlood Pressure ManagementFacts, Myths & Legends Jill Bunker MSc & Wendy Callister
Clinical Nurse Specialist
Hypertension and Cardiovascular Disease Prevention
Peart-Rose Clinic & Clinical Investigation Unit
24th September 2008
2. High BP estimated to account for 6% of deaths worldwide
It’s the most common treatable risk factor for CVD
Majority of patients BPs remain uncontrolled
Hypertension is sufficiently common to be a public health concern
BP control dependent on individual doctors and nurses
High BP estimated to account for 6% of deaths worldwide
It’s the most common treatable risk factor for CVD
Majority of patients BPs remain uncontrolled
Hypertension is sufficiently common to be a public health concern
BP control dependent on individual doctors and nurses
3. British Hypertension Society Guidelines for hypertension management (BHS-IV): summary (2004) Joint British Societies’ Guidelines on Prevention of Cardiovascular Disease in Clinical Practice (2006) British Cardiac Society, British Hypertension Society, Diabetes UK. HEART UK, Primary Care Cardiovascular Society, The Stroke Association.Hypertension-management of hypertension in adults in primary care (2004 and 2006). NICE. Clinical guideline 18 and 34 Different Guidelines ..
4. Topics to be covered Definition, Thresholds for intervention and treatment goals
Measurement
Evaluation of hypertensive patients
Lifestyle measures
ABPM and home monitoring
5. Classification of blood pressure levels of the British Hypertension Society High normal becoming increasingly importantHigh normal becoming increasingly important
8. BHS Guidelines Definitions
Definition, Thresholds for intervention and treatment goals
Measurement
Evaluation of hypertensive patients
Lifestyle measures
ABPM and home monitoring
10. FACTInaccurate blood pressure tests could affect millions
12. MHRA BP measurement recommendations 2005 Auscultation method: e.g Greenlight; mercury
Should be available in all clinical areas
Taught to all healthcare workers
Used to check oscillometric (automatic) monitors
Always used in certain clinical conditions: arrhythmias; pre-eclampsia; certain vascular disorders
2. Non-mercury auscultation method:
Available in all clinical areas (e.g. Accoson Greenlight 300)
Mercury Spillage kits:
Available in all clinical areas if using mercury
13. MHRA BP measurement recommendations 2005 Oscillometric monitors (automatic):
Don’t assume it’s suitable for use in diagnosis of hypertension
Oscillometric (automatic) method not suitable for all:
Arrythmias; pre-eclampsia; certain vascular diseases
Aneroid monitors:
Aneroid dial gauges easily prone to damage from dropping, causing significant errors in zero & calibration
7. Calibration/Servicing
Calibrate and service all your monitors regularly
14. Examples of recommended BP monitors. Mercury sphygmomanometers – (gold standard).
Greenlight 300 (accoson)
Independently validated automated upper arm devices
Consider MANDAUS 11 for community use
(details available BHS website)
15. Measuring Blood Pressure
17. BHS Guidelines Definitions
Measurement
Evaluation of hypertensive patients
Lifestyle measures
ABPM and home monitoring
19. Evaluation of hypertensive patients Causes of hypertension (in 5% of patients)
Drugs (NSAIDS, oral contraceptions, steroids, liquorice, some cold cures)
Renal disease (present, past or family history, proteinuria or haematuria: palpable kidney(s) – polycystic, hydronephrosis, or neoplasm)
Renovascular disease (abdominal or loin bruit)
Phaeochromocytoma (paroxysmal symptoms)
Conn’s syndrome (muscle weakness, polyuria, hypokalaemia)
Coarctation (radio-femoral delay or weak femoral pulses)
Cushing’s (general appearance)
23.
24. BHS Guidelines
Definitions
Measurement
Evaluation of hypertensive patients
Lifestyle measures
ABPM and home monitoring
25. This table can be found in the BHS guidelines
It shows what level of systolic BP reduction can be expected with life style changes This table can be found in the BHS guidelines
It shows what level of systolic BP reduction can be expected with life style changes
26. BHS Guidelines Definitions
Measurement
Evaluation of hypertensive patients
Lifestyle measures
ABPM and home monitoring
27. Home/self BP monitoring Advise patients on accurate, independently validated, well maintained monitors
Advise use of appropriate cuff size
Wrist monitors are not recommended
Suggested measurement routine for patients
Measure BP for 7 days prior to appointment
Record BP twice a day. Morning and evening
Discard first 24 hours of readings
Take an average of at least 12 of these readings
29. Interpreting results For both 24 hour Ambulatory BP monitoring and Home Monitor readings
Add 10/5 mmHg to average daytime pressure.
e.g. day-time average pressure = 158/89
add 10/5
adjusted reading = 168/94
Home BP <130/85 probably considered normal.
31. Reasons for inadequate control of BP? Ineffective drugs?
Resistant hypertension?
Guideline confusion?
Drug costs?
Drug side-effects?
Poor adherence/compliance?
Physician inertia?
32. Compliance/Adherence issues Side-effects?
Asymptomatic disease?
feel worse with treatment
may not protect from …
Cost?
Memory?
Understanding?
33. For information on… Hypertension Management Guidelines, Recommendations for combining blood pressure lowering drugs, BP measuring recommendations, Validated BP monitors, CVD risk prediction chartCHD risk calculator www.bhsoc.org.uk